Intra-Cellular Ther (ITCI)
$18.93 0.00 (0.00%)
7:04 EDT ITCI Stock Quote Delayed 30 Minutes
Previous Close $18.93
Market Cap 1.04B
PE Ratio -8.80
Volume (Avg. Vol.) 1
Day's Range 18.93 - 18.93
52-Week Range 6.75 - 43.56
Dividend & Yield N/A (N/A)
ITCI Stock Predictions, Articles, and Intra-Cellular Ther News
- From InvestorPlace
- From the Web
Why Intra-Cellular Therapies Inc (ITCI), Weatherford International Plc (WFT) and Newell Brands Inc (NWL) Are 3 of Today’s Worst Stocks
Newell Brands (NWL), Intra-Cellular Therapies (ITCI) and Weatherford (WFT) shareholders ended up wishing the weekend had lasted one more day.
The overall ratings of 16 Pharmaceuticals stocks are down on Portfolio Grader this week. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
This week, the ratings of 14 Pharmaceuticals stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
The ratings of 5 Pharmaceuticals stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
The following stocks were the biggest movers and shakers in the Manufacturing sector today.
3 Stocks to Watch on Thursday: Pier 1 Imports Inc (PIR), Intra-Cellular Therapies Inc (ITCI) and Progress Software Corporation (PRGS)
Intra-Cellular Therapies (INTC) is cratering on drug trial news, Pier 1 (PIR) lost less than expected and Progress Software (PRGS) disappointed Wall Street.
From Seeking Alpha
Pacific Ethanol (NASDAQ:PEIX) +5.25% AH regained compliance with NASDAQ Listing Rule requiring to maintain a minimum closing bid price of $1.00/share.The company has now cancelled its earlier scheduled special meeting on August 27, 2020 for authorizing a reverse stock split and now intends to schedule and hold its annual meeting of stockholders later in 2020.
Navellier RatingsPowered by Portfolio Grader